Bio-similar drug development and accessible drugs in the market for the treatment of Alzheimer's Disease: Current status
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2022.
Main Author: | Tamanna, Mst. Taskia |
---|---|
Other Authors: | Sharmin, Dr. Sabrina |
Format: | Thesis |
Language: | English |
Published: |
Brac University
2023
|
Subjects: | |
Online Access: | http://hdl.handle.net/10361/18146 |
Similar Items
-
Progress of finding latent therapeutic activity of vaccine for Alzheimer’s disease
by: Hassan, Md. Muhtaz
Published: (2020) -
Role of protein’s and future treatment options for Alzheimer’s Disease
by: Islam, Md. Irfath
Published: (2023) -
Efficacy of Rivastigmine in Alzheimer’s disease- A structured seview
by: Alim, Abdul
Published: (2023) -
Marine compounds in the treatment of Alzheimer’s disease
by: Parveen, Sanjana
Published: (2022) -
Gender-specific Rhabdomyolysis risk in Alzheimer’s disease patients receiving memantine: a pharmacovigilance study
by: Tabassum, Nadira
Published: (2024)